LINC01804

Across TCGA pan-cancer cohorts, LINC01804 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated LINC01804 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher LINC01804 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01804 expression acts as an unfavorable survival marker, although some lineages such as SARC and READ show a favorable association.

KIRC, COAD, and DLBC are the cancer types where LINC01804 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Median	All	0.536	0.683	<.001	98	view →
COAD	OS	Tertile	II,III,IV	0.711	0.868	.002	90	view →
DLBC	DFS	Median	II,III,IV	0.403	1.000	.001	81	view →
CHOL	OS	Tertile	III,IV	0.024	0.772	.008	72	view →
UCEC	DFS	Quartile	All	0.564	0.710	.003	64	view →
BRCA	DFS	Tertile	All	0.570	1.000	.033	36	view →
THYM	OS	Tertile	All	0.694	1.000	.001	32	view →
LIHC	OS	Tertile	II,III,IV	0.428	0.738	<.001	30	view →
KIRP	OS	Tertile	II,III,IV	0.111	0.769	<.001	27	view →
SARC	DFS	Tertile	All	0.732	0.584	.037	12	view →
KICH	OS	Tertile	III,IV	0.178	0.847	<.001	9	view →
THCA	OS	Median	All	0.966	0.991	.020	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

LINC01804–KIRC (OS)

Open the KIRC breakdown →